U.S. Bioequivalence Studies Market, 2023-2030

Name: U.S. Bioequivalence Studies Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The bioequivalence studies market in the United States is expected to reach a projected revenue of US$ 469.3 million by 2030. A compound annual growth rate of 8.4% is expected of the United States bioequivalence studies market from 2024 to 2030.

U.S. bioequivalence studies report molecule type outlook (Revenue, USD million, 2018-2030)
- Small Molecule
- Large Molecule
U.S. bioequivalence studies report dosage form outlook (Revenue, USD million, 2018-2030)
- Solid Oral Dosage
- Parenteral Formulations
- Topical Products
- Others
U.S. bioequivalence studies report therapeutic area outlook (Revenue, USD million, 2018-2030)
- Oncology
- Neurology
- Metabolic Disorders
- Hematology
- Immunology
- Others

U.S. Bioequivalence Studies Market, 2023-2030

Sign up - it's easy, and free!